Re-evaluating early high-frequency oscillatory ventilation in moderate-to-severe pediatric ARDS: evidence from a genetic matching analysis

Read full text Summarise with VIRAT
Authors: Feifan Jin, Ziqing Quan, Hongxing Dang
Cited by: 0
References: 28

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and aims Pediatric acute respiratory distress syndrome (PARDS) carries high mortality in pediatric intensive care units (PICUs). The clinical benefit of early high-frequency oscillatory ventilation (HFOV) for moderate-to-severe PARDS remains controversial. This study aimed to compare clinical outcomes between HFOV and conventional mechanical ventilation (CMV) using a robust genetic matching approach. Methods In this retrospective case–control study, children with moderate-to-severe PARDS admitted to the two PICUs of Chongqing Medical University from January 2012 to June 2024 were analyzed in a pre-specified 7-day landmark cohort (sustained invasive MV ≥ 7 days). Genetic matching in R software was applied to balance baseline characteristics between HFOV and CMV groups. The primary outcome was 28-day mortality; secondary outcomes included ventilator-free days (VFD), PICU-free days (IFD), survival time, and survival rates stratified by pre-intubation PaO 2 /FiO 2 (P/F) ratios. Results After matching, 53 patients were included in each group with well-balanced baseline variables. Sensitivity (Rosenbaum bounds) and robustness (nearest-neighbor matching) analyses confirmed the stability of the matched results. The 28-day mortality was significantly higher in the HFOV group than in the CMV group (49.1% vs. 28.3%, p = 0.04), whereas VFD and IFD did not differ significantly. Logistic regression indicated that HFOV was independently associated with higher 28-day mortality [adjusted OR = 2.47 (95% CI 1.02–5.98), p = 0.04]. In stratified analysis, the 28-day survival rate for moderate PARDS (200 ≥ P/ F > 100) was markedly lower with HFOV than CMV (0.41 vs. 0.82, p = 0.01). Conclusion In this 7-day landmark cohort, early HFOV may not provide extra benefit in moderate-to-severe PARDS and might be associated with higher mortality, whereas CMV was linked with lower observed 28-day mortality. Further prospective studies are warranted.

Fields of Study & Subjects

Respiratory Support and Mechanisms Neonatal Respiratory Health Research Nosocomial Infections in ICU

Publication details

Journal / source
Frontiers in Medicine
Volume
13
Pages
1725518–1725518
Publication date
25 March 2026
Language
EN